Sign in

Sriram Neelamegham

@neel-lab.bsky.social
75 followers 73 following 5 posts

Professor, University at Buffalo: Molecular/cell engineering, glycans, informatics, human diseases, and anything science related.

PostsRepliesMedia
Sriram Neelamegham @neel-lab.bsky.social · 22/05/2026
A tribute to a legend, Harry Schachter, and pioneering discoveries in O- and N-glycosylation pathways, written with Inka Brockhausen and Khushi Matta: authors.elsevier.com/sd/article/S...
authors.elsevier.com
ScienceDirect.com | Science, health and medical journals, full text articles and books.
031
Reposted by Sriram Neelamegham
SFG @sfglycobiology.bsky.social · 27/02/2026
SAVE THE DATE: The 53rd Society for Glycobiology Annual Meeting (SFG 2026) is heading to Atlanta! Join the global glycobiology community November 8–11, 2026 at the Emory Conference Center Hotel for four days of cutting‑edge science, collaboration, and discovery. lnkd.in/g75JFg-h #SFG2026
Registration and abstract submissions will open in June! Bookmark the 2026 SFG Annual Meeting webpage and stay tuned for more information: https://lnkd.in/g75JFg-h
0138
Reposted by Sriram Neelamegham
Ethan Goddard-Borger @ethangbaus.bsky.social · 04/02/2026
🚨 Our new paper is out today in Nature Chemical Biology: “Pan-specific antibodies to uncover bacterial pseudaminylation” doi.org/10.1038/s415... This is the product of a collaboration between many teams, led by @nickescott.bsky.social, @payneresearch.bsky.social and myself. 1/6
doi.org
Uncovering bacterial pseudaminylation with pan-specific antibody tools - Nature Chemical Biology
Pseudaminic acids (Pse) are a family of carbohydrates found within bacterial lipopolysaccharides, capsular polysaccharides and glycoproteins. Now, monoclonal antibodies have been developed that recogn...
2258
Reposted by Sriram Neelamegham
Anne Imberty @anneimb.bsky.social · 18/12/2025
Major update for unilectin.unige.ch with now more than 2800 3D-structures with annotation, literature and details of interaction!! HumanLectome also up to date. Thanks to Boris Schnider at @sib.swiss and @glycoexpasy.bsky.social for super work. More exciting news soon with LectomeXplore upgrade
0119
Reposted by Sriram Neelamegham
Waggoner Lab @labwaggoner.bsky.social · 11/12/2025
Single-cell glycome and transcriptome profiling enabled by a library of anti-glycan antibodies www.cell.com/cell-chemica... @cp-cellchembiol.bsky.social
085
Sriram Neelamegham @neel-lab.bsky.social · 07/11/2025
GlycoEnzDB paper & website out in Glycobiology! ~400 enzymes with functions & pathways regulating human glycosylation. Thanks to Essentials editors for permitting textbook figures/text to train GPT. "GlycoEnzDB: A database of enzymes involved in human glycosylation": academic.oup.com/glycob/artic...
academic.oup.com
GlycoEnzDB: A database of enzymes involved in human glycosylation
Abstract. The glycan distribution on cells is governed by the activities of different families of enzymes that are together called “glycoEnzymes.” These in
030
Reposted by Sriram Neelamegham
Lara K. Mahal @glycocode.bsky.social · 04/11/2025
Sweet new #glycotime science out of the Huang lab looking at roles of glyco in the placenta.🧪🧪
083
Reposted by Sriram Neelamegham
John Monyror @johnmonyror.bsky.social · 04/11/2025
Hi bluesky! I'm very happy to share our new article out now in #ScienceAdvances! Gangliosides modulate extracellular vesicle secretion, with implications for neurodegenerative disease and other conditions with altered ganglioside levels. www.science.org/doi/10.1126/... #glycotime
121
Reposted by Sriram Neelamegham
GlyGen @glygen.bsky.social · 31/10/2025
📢 Join us for the next GlySpace Alliance Webinar! 🗓️ Tuesday, November 18, 2025 | 10 AM ET 🎙️Dr. Rene Ranzinger presents: “New Features and Tools in GlyGen v2.9” 🗒️Details: wiki.glygen.org/GlySpace_All... 🔗 Join our mailing list: docs.google.com/forms/d/e/1F... #glycotime #glygen #researchtools
032
Reposted by Sriram Neelamegham
Lara K. Mahal @glycocode.bsky.social · 01/11/2025
Happy Halloween from GIA. Enjoy a free #glycotime treat. Sign up for next week’s #GIA2025 Symposium today. glyco-alberta.ca/gia2025/
Glycogang member Glucose flying on a broomstick as a witch with candy
021
Reposted by Sriram Neelamegham
Glycomics Institute of Alberta @giaglyco.bsky.social · 20/10/2025
The countdown is on! With GIA2025 less than 3 weeks away, we’d like to introduce our Keynote Speakers that we will have the privilege of hosting this year. First is Dr. Sriram Neelameghan from the University at Buffalo whose lab studies the area of Systems Glycobiology. @neel-lab.bsky.social
153
Reposted by Sriram Neelamegham
Elisa Fadda @elisafadda.bsky.social · 15/10/2025
Just on time for my intro lecture on #glycotime in 3D ⤵️🎉 The first successful human transplant of a kidney converted from blood type A to universal type O used special enzymes developed by the team led by Prof Stephen Withers and Prof Jayachandran Kizhakkedathu at UBC news.ubc.ca/2025/10/univ...
news.ubc.ca
UBC enzyme technology clears first human test toward universal donor organs for transplantation - UBC News
UBC-developed enzymes successfully converted a kidney to universal type O for transplant, marking a major step toward faster, more compatible organ donations.
1199
Reposted by Sriram Neelamegham
SFG @sfglycobiology.bsky.social · 08/10/2025
🚨 Don't Miss These Dynamic Workshops at the SFG 2025 Annual Meeting! 🚨 Workshops and satellite sessions start on Sunday, November 9 and continue over lunch on Monday, November 10. For all details and registration check out the programme at a glance ⬇️ sfg.memberclicks.net/2025-annual-...
media.tenor.com
a group of gnomes are sitting around a table in a cartoon
ALT: a group of gnomes are sitting around a table in a cartoon
033
Reposted by Sriram Neelamegham
Stefan Ruhl 🦷💧🦠 @spit-lab.bsky.social · 03/08/2025
❗️❗️❗️👄👄 #MOUTH 👄👄 🦷🦷 #TEETH 🦷🦷 💧💧 #SALIVA 💧💧🦠🦠 #MICROBIOME🦠🦠 🍭🍭 #glycotime 🍭🍭 ❗️❗️❗️ ❗️We are hiring❗️Check out this full-time tenure track academic faculty position in the #UBSDM's Department of Oral Biology. ms.spr.ly/6045sKrT9
ubjobs.buffalo.edu
Assistant Professor/Associate Professor, Oral Biology
The University at Buffalo School of Dental Medicine (SDM) invites applications from qualified early- to mid-career oral health scientists and/or clinician-scientists for a full-time tenure track acade...
023
Reposted by Sriram Neelamegham
Brett Garabedian, PhD @brettgarabedian.bsky.social · 30/07/2025
“… immediately halt the issuing of research grants, research and development contracts, and training awards during a “pause” of unspecified duration. “ www.statnews.com/2025/07/29/t...
statnews.com
Trump administration blocks NIH from awarding any research grants and contracts
The order applies to the entirety of new and, possibly, ongoing research grant dollars that go to universities and academic medical centers.
101
Reposted by Sriram Neelamegham
Leonhard Möckl @lmoeckl.bsky.social · 02/05/2025
GLYCAN ATLASSING: NANOSCALE ANALYSIS OF GLYCOCALYX ARCHITECTURE ENABLES FUNCTIONAL TRACING OF CELL STATE 🍭🔬🧬 Don’t judge a book by its cover - judge a cell by its cover! We can now trace how cell state is encoded in glycocalyx state. #glycotime #microscopy www.biorxiv.org/content/10.1...
82211
Reposted by Sriram Neelamegham
Nature Nanotechnology @natnano.nature.com · 28/07/2025
New paper online: Ångström-resolution imaging of cell-surface glycans. The molecular organization of sugars in the native #glycocalyx has been resolved at 9 ångström using bioorthogonal metabolic labeling and #superresolution imaging of DNA barcodes. #Glycotime www.nature.com/articles/s41...
nature.com
Ångström-resolution imaging of cell-surface glycans - Nature Nanotechnology
By combining bioorthogonal metabolic labelling and resolution enhancement through sequential imaging of DNA barcodes, the molecular organization of individual sugars in the native glycocalyx has been ...
23619
Sriram Neelamegham @neel-lab.bsky.social · 24/07/2025
Happy to share 3rd paper in a series on glycoT engineering. Prior work in Small (pubmed.ncbi.nlm.nih.gov/40417887) & Nature Commun. (pubmed.ncbi.nlm.nih.gov/40681527/), and most recent in Glycobiology: "Protein engineering strategies to develop lectins by design": academic.oup.com/glycob/artic...
academic.oup.com
Protein engineering strategies to develop lectins by design
Abstract. Glycans regulate a wide array of biological processes, making them central to studies of cell biology. Thus, it is essential to characterize the
010
Sriram Neelamegham @neel-lab.bsky.social · 09/07/2025
Sharing link to our paper on high throughput engineering of glycosyltransferases— you can use it to study structure-function relations, discover disease associated mutations, make super enzymes with unique properties etc.: onlinelibrary.wiley.com/share/VGWXBG...
onlinelibrary.wiley.com
Mammalian Cell Surface Display for High‐Throughput Protein Engineering of Glycosyltransferases
You have to enable JavaScript in your browser's settings in order to use the eReader.
000
Sriram Neelamegham @neel-lab.bsky.social · 08/07/2025
Link to our collaboration with Rudi Gunawan on using deep learning for glycomics: www.biorxiv.org/content/10.1...
biorxiv.org
Transformer-based Deep Learning for Glycan Structure Inference from Tandem Mass Spectrometry
Glycans play critical roles in diverse biological processes, but their structural analysis by tandem mass spectrometry (MS/MS) remains a major challenge due to their branched structure and stereochemistry. Traditional computational methods, such as database searching, are constrained by the scope of existing libraries and can be computationally intensive. While recent deep learning models have advanced the field, they often struggle to capture the complex, long-range dependencies within MS/MS spectra required for accurate inference. To address these challenges, we present GlycoBERT and GlycoBART, novel transformer-based models for glycan structure prediction from MS/MS data. GlycoBERT, a sequence classifier, achieves 95.1% structural accuracy on test data, surpassing the current state-of-the-art deep learning model, CandyCrunch. However, classification-based methods are inherently limited to predicting structures present in the training data. To overcome this, we developed GlycoBART, a generative sequence-to-sequence model capable of de novo glycan inference. On independent validation datasets, both models demonstrate robust performance. Critically, when applied to an MS/MS dataset from human embryonic kidney cells, GlycoBART generated two de novo glycan structures absent from the training set, one of which is a novel structure not catalogued in major glycan databases. Together, GlycoBERT and GlycoBART establish a new benchmark for glycan analysis, offering a powerful framework that enables more accurate and comprehensive exploration of glycan diversity and discovery. ### Competing Interest Statement The authors have declared no competing interest. National Heart Lung and Blood Institute, https://ror.org/012pb6c26, HL103411
031
Reposted by Sriram Neelamegham
The NCFG @thencfg.bsky.social · 08/07/2025
📢New article alert! 'Blood group O expression in normal tissues and tumors', just published in FEBS Journal, highlights findings using our lamprey-derived monoclonal antibodies towards specific H antigen epitopes. Read at: febs.onlinelibrary.wiley.com/doi/10.1111/... #glycotime #glycans #bloodgroups
febs.onlinelibrary.wiley.com
FEBS Press
The H antigen (O blood group), the precursor to A and B blood groups, is expressed on human erythrocytes. Two novel monoclonal antibodies generated using sea lamprey immunization, Tn4-31L and OmcFL3-...
052